ArticleRheumatology international2026
Large language models in the diagnosis and treatment of immunosuppression-related infections in rheumatic diseases: a comparative, vignette-based study.
Article in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study compared the diagnostic accuracy, initial test selection, and initial treatment choices of three current-generation Large Language Models (LLMs) with those of two infectious disease specialists in managing infectious complications in patients with immunosuppressed rheumatic disease. This cross-sectional comparative study utilized 100 standardized Turkish-language clinical vignettes, developed by an expert committee, encompassing ten infection categories: viral, bone/joint, respiratory, central nervous system, gastrointestinal, genitourinary, skin and soft tissue, rare diseases, vaccination and prophylaxis, and adverse drug reactions. A prespecified reference standard, based on current clinical practice guidelines (ACR, EULAR, KLİMİK, IDSA, ATS, WHO, SANJO/EBJIS), was established prior to data collection. Three LLMs (Gemini 3.1 Pro, ChatGPT 5.5, Claude 4.7 Opus) and two blinded infectious disease specialists, operating under closed-book conditions, answered the same vignettes across three domains: diagnosis, initial diagnostic work-up, and initial treatment. Responses were evaluated dichotomously as correct or incorrect according to the reference standard. Diagnostic accuracy was 91% and 93% for the two human experts, compared to 99%, 97%, and 100% for Gemini 3.1 Pro, ChatGPT 5.5, and Claude 4.7 Opus, respectively. This pattern was consistent across all three domains (Cochran Q, all p ≤ 0.003). Human experts achieved complete case management in 83% and 90% of vignettes, while the LLMs achieved 97-100% (p < 0.001). Of 40 pairwise comparisons, 10 showed Bonferroni-corrected significance, all in human-versus-model comparisons. In this vignette-based comparison, all three LLMs answered a higher proportion of items correctly than the two participating infectious disease specialists in all three domains. As the cases were standardized written vignettes with a single prespecified correct answer, and only two human comparators were available, this reflects performance on a structured written task rather than superiority in clinical care. These findings suggest that LLMs could serve as a complementary decision-support tool, especially for identifying rare or opportunistic diagnoses, but should not replace specialists without further prospective, real-world validation.
Indexed as
Identifiers
42853428What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.